Cargando…
Steroid-refractory immune thrombocytopenia in the era of the new thrombomimetic drugs: is there still a role for rituximab?
Autores principales: | Palombi, Massimiliano, Scaramucci, Laura, Giovannini, Marco, Trawinska, Malgorzata Monika, Niscola, Pasquale, de Fabritiis, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828534/ https://www.ncbi.nlm.nih.gov/pubmed/27104196 http://dx.doi.org/10.5045/br.2016.51.1.66 |
Ejemplares similares
-
Immune Thrombocytopenia Resolved by Eltrombopag in a Carrier of Glucose-6-Phosphate Dehydrogenase Deficiency
por: Scaramucci, Laura, et al.
Publicado: (2016) -
Managing myelodysplastic syndromes in very old patients: a teaching case report
por: Niscola, Pasquale, et al.
Publicado: (2013) -
Long-term survival of a patient with bone marrow gelatinous degeneration of idiopathic origin
por: Niscola, Pasquale, et al.
Publicado: (2012) -
Late but effective long-term response to splenectomy in the treatment of immune thrombocytopenia
por: Scaramucci, Laura, et al.
Publicado: (2013) -
Authors’ Reply
por: Tendas, Andrea, et al.
Publicado: (2011)